Justin J. McAnear's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 2,961 Class A Common Stock done at an average price of $22.5 . Disclosure was reported to the exchange on Aug. 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc Ordinary | Justin J. McAnear | Former Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.53 per share. | 22 Aug 2024 | 2,961 | 143,242 (0%) | 0% | 22.5 | 66,710 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 24.30 per share. | 22 May 2024 | 2,936 | 146,203 (0%) | 0% | 24.3 | 71,355 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 53,312 | 148,552 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | McAnear Justin J. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 46.34 per share. | 22 Feb 2024 | 1,865 | 95,240 (0%) | 0% | 46.3 | 86,432 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 45.78 per share. | 22 Aug 2023 | 1,678 | 98,784 (0%) | 0% | 45.8 | 76,821 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 565 | 100,462 (0%) | 0% | 55.1 | 31,111 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 465 | 101,468 (0%) | 0% | 55.1 | 25,604 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 441 | 101,027 (0%) | 0% | 55.1 | 24,283 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.07 per share. | 23 May 2023 | 194 | 101,933 (0%) | 0% | 55.1 | 10,683 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 25,991 | 101,510 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 25,991 | 25,991 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 12,996 | 12,996 | - | - | Performance based Restricted Stock Units | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 47.75 per share. | 22 Feb 2023 | 1,245 | 75,519 (0%) | 0% | 47.8 | 59,453 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 686 | 77,704 (0%) | 0% | 34.1 | 23,369 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 652 | 77,052 (0%) | 0% | 34.1 | 22,212 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 288 | 76,764 (0%) | 0% | 34.1 | 9,811 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 40,593 | 40,593 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 40,593 | 40,593 | - | - | Performance-based Restricted Stock Units | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 20,297 | 78,389 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.19 per share. | 23 Aug 2022 | 987 | 58,092 (0%) | 0% | 35.2 | 34,734 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 48.76 per share. | 23 May 2022 | 967 | 59,079 (0%) | 0% | 48.8 | 47,155 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 40.49 per share. | 13 May 2022 | 158 | 60,046 (0%) | 0% | 40.5 | 6,397 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 53,392 | 53,392 | - | - | Stock Option (Right to Buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 21,357 | 59,888 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 78.60 per share. | 22 Feb 2022 | 288 | 38,531 (0%) | 0% | 78.6 | 22,637 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 350,159 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 03 Jan 2022 | 10,000 | 48,819 (0%) | 0% | 5.0 | 50,400 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 145.96 per share. | 03 Jan 2022 | 4,083 | 41,153 (0%) | 0% | 146.0 | 595,937 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 145.16 per share. | 03 Jan 2022 | 3,583 | 45,236 (0%) | 0% | 145.2 | 520,115 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 146.92 per share. | 03 Jan 2022 | 1,334 | 39,819 (0%) | 0% | 146.9 | 195,988 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 149.18 per share. | 03 Jan 2022 | 500 | 38,819 (0%) | 0% | 149.2 | 74,589 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 148.04 per share. | 03 Jan 2022 | 500 | 39,319 (0%) | 0% | 148.0 | 74,022 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Dec 2021 | 10,000 | 48,819 (0%) | 0% | 5.0 | 50,400 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 10,000 | 360,159 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 147.62 per share. | 01 Dec 2021 | 2,700 | 42,121 (0%) | 0% | 147.6 | 398,563 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 145.54 per share. | 01 Dec 2021 | 2,462 | 46,357 (0%) | 0% | 145.5 | 358,323 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 146.49 per share. | 01 Dec 2021 | 1,536 | 44,821 (0%) | 0% | 146.5 | 225,014 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 148.48 per share. | 01 Dec 2021 | 1,302 | 40,819 (0%) | 0% | 148.5 | 193,321 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 149.40 per share. | 01 Dec 2021 | 600 | 40,219 (0%) | 0% | 149.4 | 89,643 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 150.71 per share. | 01 Dec 2021 | 500 | 39,719 (0%) | 0% | 150.7 | 75,357 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 151.31 per share. | 01 Dec 2021 | 300 | 39,419 (0%) | 0% | 151.3 | 45,394 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 151.80 per share. | 01 Dec 2021 | 300 | 39,119 (0%) | 0% | 151.8 | 45,539 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 153.86 per share. | 01 Dec 2021 | 200 | 38,919 (0%) | 0% | 153.9 | 30,772 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 155.55 per share. | 01 Dec 2021 | 100 | 38,819 (0%) | 0% | 155.6 | 15,555 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 148.38 per share. | 22 Nov 2021 | 281 | 38,819 (0%) | 0% | 148.4 | 41,695 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 10,000 | 370,159 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Nov 2021 | 10,000 | 49,100 (0%) | 0% | 5.0 | 50,400 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 163.34 per share. | 01 Nov 2021 | 4,667 | 43,633 (0%) | 0% | 163.3 | 762,314 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 164.05 per share. | 01 Nov 2021 | 4,333 | 39,300 (0%) | 0% | 164.1 | 710,847 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 162.16 per share. | 01 Nov 2021 | 500 | 48,300 (0%) | 0% | 162.2 | 81,079 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 160.48 per share. | 01 Nov 2021 | 300 | 48,800 (0%) | 0% | 160.5 | 48,143 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 164.96 per share. | 01 Nov 2021 | 200 | 39,100 (0%) | 0% | 165.0 | 32,992 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Oct 2021 | 10,000 | 49,100 (0%) | 0% | 5.0 | 50,400 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 10,000 | 380,159 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 143.79 per share. | 01 Oct 2021 | 5,666 | 40,300 (0%) | 0% | 143.8 | 814,725 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 142.80 per share. | 01 Oct 2021 | 2,500 | 45,966 (0%) | 0% | 142.8 | 357,008 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 144.57 per share. | 01 Oct 2021 | 1,200 | 39,100 (0%) | 0% | 144.6 | 173,485 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 141.96 per share. | 01 Oct 2021 | 634 | 48,466 (0%) | 0% | 142.0 | 90,003 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 161.85 per share. | 23 Aug 2021 | 270 | 39,100 (0%) | 0% | 161.8 | 43,699 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 10,000 | 400,159 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 02 Aug 2021 | 10,000 | 49,370 (0%) | 0% | 5.0 | 50,400 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 181.31 per share. | 02 Aug 2021 | 2,302 | 40,870 (0%) | 0% | 181.3 | 417,376 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 180.29 per share. | 02 Aug 2021 | 2,298 | 43,172 (0%) | 0% | 180.3 | 414,304 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 179.28 per share. | 02 Aug 2021 | 2,202 | 45,470 (0%) | 0% | 179.3 | 394,780 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 178.35 per share. | 02 Aug 2021 | 1,698 | 47,672 (0%) | 0% | 178.4 | 302,840 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 182.16 per share. | 02 Aug 2021 | 700 | 40,170 (0%) | 0% | 182.2 | 127,514 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 183.30 per share. | 02 Aug 2021 | 500 | 39,670 (0%) | 0% | 183.3 | 91,650 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 184.52 per share. | 02 Aug 2021 | 300 | 39,370 (0%) | 0% | 184.5 | 55,357 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 10,000 | 410,159 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Jul 2021 | 10,000 | 49,370 (0%) | 0% | 5.0 | 50,400 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 190.66 per share. | 01 Jul 2021 | 2,800 | 43,870 (0%) | 0% | 190.7 | 533,859 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 189.85 per share. | 01 Jul 2021 | 2,700 | 46,670 (0%) | 0% | 189.9 | 512,601 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 191.73 per share. | 01 Jul 2021 | 1,500 | 42,370 (0%) | 0% | 191.7 | 287,602 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 193.76 per share. | 01 Jul 2021 | 1,400 | 40,170 (0%) | 0% | 193.8 | 271,268 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 192.95 per share. | 01 Jul 2021 | 800 | 41,570 (0%) | 0% | 192.9 | 154,358 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 194.81 per share. | 01 Jul 2021 | 700 | 39,470 (0%) | 0% | 194.8 | 136,364 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 195.82 per share. | 01 Jul 2021 | 100 | 39,370 (0%) | 0% | 195.8 | 19,582 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 10,000 | 420,159 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Jun 2021 | 10,000 | 49,011 (0%) | 0% | 5.0 | 50,400 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 175.77 per share. | 01 Jun 2021 | 2,906 | 39,811 (0%) | 0% | 175.8 | 510,786 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 171.59 per share. | 01 Jun 2021 | 2,500 | 46,511 (0%) | 0% | 171.6 | 428,985 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 174.93 per share. | 01 Jun 2021 | 1,994 | 42,717 (0%) | 0% | 174.9 | 348,808 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 173.94 per share. | 01 Jun 2021 | 1,000 | 44,711 (0%) | 0% | 173.9 | 173,944 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 172.85 per share. | 01 Jun 2021 | 800 | 45,711 (0%) | 0% | 172.8 | 138,279 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 180.02 per share. | 01 Jun 2021 | 300 | 39,011 (0%) | 0% | 180.0 | 54,007 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 178.07 per share. | 01 Jun 2021 | 300 | 39,511 (0%) | 0% | 178.1 | 53,420 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 179.21 per share. | 01 Jun 2021 | 200 | 39,311 (0%) | 0% | 179.2 | 35,842 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 03 May 2021 | 10,000 | 40,357 (0%) | 0% | 5.0 | 50,400 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 10,000 | 430,159 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 192.46 per share. | 03 May 2021 | 3,706 | 31,451 (0%) | 0% | 192.5 | 713,241 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 191.77 per share. | 03 May 2021 | 2,700 | 35,157 (0%) | 0% | 191.8 | 517,783 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 190.63 per share. | 03 May 2021 | 1,900 | 37,857 (0%) | 0% | 190.6 | 362,191 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 193.40 per share. | 03 May 2021 | 794 | 30,657 (0%) | 0% | 193.4 | 153,560 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 189.57 per share. | 03 May 2021 | 600 | 39,757 (0%) | 0% | 189.6 | 113,743 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 194.92 per share. | 03 May 2021 | 200 | 30,457 (0%) | 0% | 194.9 | 38,984 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 198.09 per share. | 03 May 2021 | 100 | 30,357 (0%) | 0% | 198.1 | 19,809 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Apr 2021 | 10,000 | 40,357 (0%) | 0% | 5.0 | 50,400 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 10,000 | 440,159 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 185.02 per share. | 01 Apr 2021 | 3,795 | 32,157 (0%) | 0% | 185.0 | 702,152 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 184.12 per share. | 01 Apr 2021 | 3,205 | 35,952 (0%) | 0% | 184.1 | 590,096 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Justin J. McAnear | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 185.76 per share. | 01 Apr 2021 | 1,800 | 30,357 (0%) | 0% | 185.8 | 334,361 | Class A Common Stock |